INV-17

N/A

Report date: 2022/07/11 15:23:25
NME

Base Information

Drug NameINV-17
Drug Alias NameINV-17
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNuclear receptor ROR-gamma inverse agonists
TargetsNuclear receptor ROR-gamma
Therapy Area/IndicationsRare DiseasesImmune System DiseasesEye Diseases +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesInnovimmune Biotherapeutics Holding LLC
China Registration ClassN/A

Develop Information

Active CompaniesInnovimmune Biotherapeutics Holding LLC
Inactive CompaniesN/A
Active IndicationsRare DiseasesImmune System DiseasesEye Diseases +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A